Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber
The Food and Drug Administration (FDA) is classifying the medial knee implanted shock absorber into...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- June 29, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Food and Drug Administration (FDA) is classifying the medial knee implanted shock absorber into...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Medicaid Program; Community Engagement Requirement for Certain Individuals
Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of...
Center for Scientific Review; Notice of Closed Meetings
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Care Coordination Program Performance Improvement Measures, OMB No. 0906-0024-Revision
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Req...